Antiviral agent comprising RNA oligonucleotideDiscovery of Multi-purpose, RNA-based Immunotherapeutics

Cited 0 time in webofscience Cited 0 time in scopus
  • Hit : 68
  • Download : 0
The present invention provides an antiviral agent comprising an RNA oligonucleotide having a particular sequence and structure. Specifically, when a cell line is treated with an RNA oligonucleotide having specific sequence and helical bend structure according to the present invention, the expression of interferon-β or ISG56 is increased and anti-viral activating is exhibited. Thus, a composition comprising the RNA oligonucleotide can be used as an antiviral agent
Assignee
KAIST
Country
US (United States)
Application Date
2016-08-29
Application Number
15310559
Registration Date
2019-12-31
Registration Number
10,519,452
URI
http://hdl.handle.net/10203/273773
Appears in Collection
CH-Patent(특허)
Files in This Item
There are no files associated with this item.

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0